KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Short-term Investments (2017 - 2025)

Emergent BioSolutions' Short-term Investments history spans 10 years, with the latest figure at $3.7 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 39.34% year-over-year to $3.7 million; the TTM value through Dec 2025 reached $3.7 million, down 39.34%, while the annual FY2025 figure was $3.7 million, 39.34% down from the prior year.
  • Short-term Investments reached $3.7 million in Q4 2025 per EBS's latest filing, roughly flat from $3.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $6.5 million in Q3 2024 to a low of $100000.0 in Q3 2022.
  • Average Short-term Investments over 4 years is $2.0 million, with a median of $500000.0 recorded in 2024.
  • Peak YoY movement for Short-term Investments: tumbled 50.0% in 2022, then skyrocketed 640.0% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $200000.0 in 2021, then crashed by 50.0% to $100000.0 in 2022, then skyrocketed by 6000.0% to $6.1 million in 2024, then tumbled by 39.34% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Short-term Investments are $3.7 million (Q4 2025), $3.7 million (Q3 2025), and $3.7 million (Q2 2025).